Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Strategies & Market Trends : True face of China -- A Modern Kaleidoscope -- Ignore unavailable to you. Want to Upgrade?

To: RealMuLan who wrote (2910)	2/28/2008 1:45:03 PM
From: RealMuLan	Read Replies (1) \| Respond to of 12464

[The US media and Americans just do NOT get it! China has NOT made enough money from these so-called manufacturing business! So importers will either have to inspect goods/drugs themselves or just take their business SOMEWHERE ELSE!!]--China SFDA: Buyers Must Vet Drug Safety By ELAINE KURTENBACH – 1 day ago SHANGHAI, China (AP) — China's drug safety agency, commenting on a probe into the recalled drug heparin, said Wednesday it enforces strict controls on chemicals used in pharmaceuticals, but that importing countries are ultimately responsible for ensuring product safety. The State Food and Drug Administration, in a statement on its Web site, said it was cooperating with a U.S. probe into a factory that makes heparin, a blood-thinning drug by Baxter International that is subject to a massive recall due to adverse patient reactions. "We attach high importance to this," the agency said in its first comment on the heparin recall. SFDA officials have not responded to repeated inquiries about the case. But the SFDA said that based on international practice, "safeguarding the legality, safety and quality of raw materials imported for use in pharmaceuticals is the responsibility of the importing country." ap.google.com